Sudan Ebolavirus Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-11-06
Clinical Trial Update: Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General Health [Phase 1]
Phase 1 trial assessing safety and immunogenicity of the rVSVΔG-SEBOV-GP vaccine against Sudan ebolavirus in healthy adults has completed.